Bank of New York Mellon’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $441K | Buy |
+201,460
| New | +$441K | ﹤0.01% | 3556 |
|
|
2024
Q1 | – | Sell |
-84,665
| Closed | -$89.7K | – | 4289 |
|
|
2023
Q4 | $89.7K | Buy |
84,665
+64,251
| +315% | +$68.1K | ﹤0.01% | 4099 |
|
|
2023
Q3 | $33.5K | Sell |
20,414
-329
| -2% | -$540 | ﹤0.01% | 4196 |
|
|
2023
Q2 | $32.6K | Sell |
20,743
-89
| -0.4% | -$140 | ﹤0.01% | 4224 |
|
|
2023
Q1 | $29.8K | Hold |
20,832
| – | – | ﹤0.01% | 4260 |
|
|
2022
Q4 | $49.2K | Buy |
20,832
+585
| +3% | +$1.38K | ﹤0.01% | 4237 |
|
|
2022
Q3 | $41K | Hold |
20,247
| – | – | ﹤0.01% | 4351 |
|
|
2022
Q2 | $45K | Sell |
20,247
-730
| -3% | -$1.62K | ﹤0.01% | 4364 |
|
|
2022
Q1 | $140K | Hold |
20,977
| – | – | ﹤0.01% | 4333 |
|
|
2021
Q4 | $116K | Hold |
20,977
| – | – | ﹤0.01% | 4381 |
|
|
2021
Q3 | $192K | Buy |
20,977
+645
| +3% | +$5.9K | ﹤0.01% | 4219 |
|
|
2021
Q2 | $226K | Buy |
20,332
+4,728
| +30% | +$52.6K | ﹤0.01% | 4053 |
|
|
2021
Q1 | $133K | Sell |
15,604
-505
| -3% | -$4.3K | ﹤0.01% | 4125 |
|
|
2020
Q4 | $94K | Hold |
16,109
| – | – | ﹤0.01% | 4079 |
|
|
2020
Q3 | $43K | Hold |
16,109
| – | – | ﹤0.01% | 4032 |
|
|
2020
Q2 | $47K | Hold |
16,109
| – | – | ﹤0.01% | 3990 |
|
|
2020
Q1 | $28K | Buy |
+16,109
| New | +$28K | ﹤0.01% | 4024 |
|
|
2019
Q1 | – | Sell |
-562
| Closed | -$35K | – | 4234 |
|
|
2018
Q4 | $35K | Buy |
+562
| New | +$35K | ﹤0.01% | 4099 |
|
|
2017
Q4 | – | Sell |
-13
| Closed | -$7K | – | 4375 |
|
|
2017
Q3 | $7K | Buy |
13
+4
| +44% | +$2.15K | ﹤0.01% | 4250 |
|
|
2017
Q2 | $8K | Sell |
9
-18
| -67% | -$16K | ﹤0.01% | 4272 |
|
|
2017
Q1 | $25K | Buy |
27
+8
| +42% | +$7.41K | ﹤0.01% | 4208 |
|
|
2016
Q4 | $55K | Buy |
+19
| New | +$55K | ﹤0.01% | 4118 |
|